Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Protara Therapeutics, Inc. (TARA) had Return on Tangible Equity of -10.36% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-14.96M |
|
-- |
|
-- |
|
$16.59M |
|
$-16.59M |
|
$1.63M |
|
$-14.96M |
|
$-14.96M |
|
$-14.96M |
|
$-14.96M |
|
$-14.96M |
|
$-14.96M |
|
$-16.59M |
|
$-16.32M |
|
42.27M |
|
42.27M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$125.09M |
|
$0.91M |
|
$31.84M |
|
$156.93M |
|
$9.76M |
|
-- |
|
$2.75M |
|
$12.51M |
|
$144.42M |
|
$144.42M |
|
$144.42M |
|
35.05M |
|
| Cash Flow Statement Financials | |
$-26.96M |
|
$-106.08M |
|
$1.74M |
|
$163.54M |
|
$32.24M |
|
$-131.30M |
|
$1.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-27.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.36% |
|
|
Return on Tangible Equity |
-10.36% |
-9.53% |
|
-10.36% |
|
$4.12 |
|
$-0.64 |
|
$-0.64 |
|